These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11255562)

  • 1. Angiogenesis and its control in the female reproductive system.
    Fraser HM; Lunn SF
    Br Med Bull; 2000; 56(3):787-97. PubMed ID: 11255562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Angiogenesis in the female reproductive processes].
    Zbucka M; Koda M; Tomaszewski J; Przystupa W; Sulkowski S; Wołczyński S
    Ginekol Pol; 2004 Aug; 75(8):649-57. PubMed ID: 15517790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis in ovarian follicular and luteal development.
    Hazzard TM; Stouffer RL
    Baillieres Best Pract Res Clin Obstet Gynaecol; 2000 Dec; 14(6):883-900. PubMed ID: 11141339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenesis in the primate ovary.
    Fraser HM; Wulff C
    Reprod Fertil Dev; 2001; 13(7-8):557-66. PubMed ID: 11999306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation and manipulation of angiogenesis in the primate corpus luteum.
    Fraser HM; Lunn SF
    Reproduction; 2001 Mar; 121(3):355-62. PubMed ID: 11226061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term administration of antivascular endothelial growth factor antibody in the late follicular phase delays follicular development in the rhesus monkey.
    Zimmermann RC; Xiao E; Husami N; Sauer MV; Lobo R; Kitajewski J; Ferin M
    J Clin Endocrinol Metab; 2001 Feb; 86(2):768-72. PubMed ID: 11158044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Luteal angiogenesis: prevention and intervention by treatment with vascular endothelial growth factor trap(A40).
    Wulff C; Wilson H; Rudge JS; Wiegand SJ; Lunn SF; Fraser HM
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3377-86. PubMed ID: 11443214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SRB Reproduction, Fertility and Development Award Lecture 2008. Regulation and manipulation of angiogenesis in the ovary and endometrium.
    Fraser HM; Duncan WC
    Reprod Fertil Dev; 2009; 21(3):377-92. PubMed ID: 19261215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of luteal angiogenesis in the primate after neutralization of vascular endothelial growth factor.
    Fraser HM; Dickson SE; Lunn SF; Wulff C; Morris KD; Carroll VA; Bicknell R
    Endocrinology; 2000 Mar; 141(3):995-1000. PubMed ID: 10698175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of angiogenesis by hypoxic stress: from solid tumours to the ovarian follicle.
    Neeman M; Abramovitch R; Schiffenbauer YS; Tempel C
    Int J Exp Pathol; 1997 Apr; 78(2):57-70. PubMed ID: 9203980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular morphogenesis in the ovary.
    Augustin HG
    Baillieres Best Pract Res Clin Obstet Gynaecol; 2000 Dec; 14(6):867-82. PubMed ID: 11141338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preovulatory treatment of mice with anti-VEGF receptor 2 antibody inhibits angiogenesis in corpora lutea.
    Zimmermann RC; Hartman T; Bohlen P; Sauer MV; Kitajewski J
    Microvasc Res; 2001 Jul; 62(1):15-25. PubMed ID: 11421657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis in developing follicle and corpus luteum.
    Tamanini C; De Ambrogi M
    Reprod Domest Anim; 2004 Aug; 39(4):206-16. PubMed ID: 15225273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis.
    Shweiki D; Itin A; Neufeld G; Gitay-Goren H; Keshet E
    J Clin Invest; 1993 May; 91(5):2235-43. PubMed ID: 7683699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogenesis during follicular development in the primate and its inhibition by treatment with truncated Flt-1-Fc (vascular endothelial growth factor Trap(A40)).
    Wulff C; Wiegand SJ; Saunders PT; Scobie GA; Fraser HM
    Endocrinology; 2001 Jul; 142(7):3244-54. PubMed ID: 11416048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
    Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenesis in the corpus luteum.
    Reynolds LP; Grazul-Bilska AT; Redmer DA
    Endocrine; 2000 Feb; 12(1):1-9. PubMed ID: 10855683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenesis in the female reproductive organs: pathological implications.
    Reynolds LP; Grazul-Bilska AT; Redmer DA
    Int J Exp Pathol; 2002 Aug; 83(4):151-63. PubMed ID: 12485460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenesis in the corpus luteum of early pregnancy in the marmoset and the effects of vascular endothelial growth factor immunoneutralization on establishment of pregnancy.
    Rowe AJ; Morris KD; Bicknell R; Fraser HM
    Biol Reprod; 2002 Oct; 67(4):1180-8. PubMed ID: 12297534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-chain bifunctional vascular endothelial growth factor (VEGF)-follicle-stimulating hormone (FSH)-C-terminal peptide (CTP) is superior to the combination therapy of recombinant VEGF plus FSH-CTP in stimulating angiogenesis during ovarian folliculogenesis.
    Trousdale RK; Pollak SV; Klein J; Lobel L; Funahashi Y; Feirt N; Lustbader JW
    Endocrinology; 2007 Mar; 148(3):1296-305. PubMed ID: 17122074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.